101 related articles for article (PubMed ID: 2696739)
1. Glucocorticoid dexamethasone reversibly complements EJ-RAS oncogene to transform mouse embryo BALB-3T3 cells.
Kovary K; Armelin MC; Armelin HA
J Cell Biochem; 1989 Dec; 41(4):171-7. PubMed ID: 2696739
[TBL] [Abstract][Full Text] [Related]
2. Ha-Ras-1 oncogene dosage differentially affects Balb/3T3 cells' growth factor requirement and tumorigenicity.
Kovary K; Armelin MC; Armelin HA
Oncogene Res; 1989; 4(1):55-64. PubMed ID: 2654813
[TBL] [Abstract][Full Text] [Related]
3. [A study on reversion of the human activated c-Ha-ras-transformed cells].
Ogiso Y
Hokkaido Igaku Zasshi; 1988 Sep; 63(5):687-97. PubMed ID: 3071518
[TBL] [Abstract][Full Text] [Related]
4. [Identification of a specific protein in flat revertant cell lines derived from ras oncogene-transformed cells].
Fujita H
Hokkaido Igaku Zasshi; 1990 Mar; 65(2):210-20. PubMed ID: 2194920
[TBL] [Abstract][Full Text] [Related]
5. alpha6beta1-Integrin, a major cell surface carrier of beta1-6-branched oligosaccharides, mediates migration of EJ-ras-transformed fibroblasts on laminin-1 independently of its glycosylation state.
Jasiulionis MG; Chammas R; Ventura AM; Travassos LR; Brentani RR
Cancer Res; 1996 Apr; 56(7):1682-9. PubMed ID: 8603420
[TBL] [Abstract][Full Text] [Related]
6. Expression and phenotypic alterations caused by an inducible transforming ras oncogene introduced into rat liver epithelial cells.
Huber BE; Cordingley MG
Oncogene; 1988 Sep; 3(3):245-56. PubMed ID: 3060790
[TBL] [Abstract][Full Text] [Related]
7. Antisense DNA inhibition of tumor growth induced by c-Ha-ras oncogene in nude mice.
Gray GD; Hernandez OM; Hebel D; Root M; Pow-Sang JM; Wickstrom E
Cancer Res; 1993 Feb; 53(3):577-80. PubMed ID: 8425190
[TBL] [Abstract][Full Text] [Related]
8. Malignant transformation of a preneoplastic hamster epidermal cell line by the EJ c-Ha-ras-oncogene.
Storer RD; Stein RB; Sina JF; DeLuca JG; Allen HL; Bradley MO
Cancer Res; 1986 Mar; 46(3):1458-64. PubMed ID: 3510726
[TBL] [Abstract][Full Text] [Related]
9. Regulation of bradykinin B2 receptors by the ras oncogene: evidence for multiple mechanisms.
Hembree TN; Leeb-Lundberg LM
J Cell Physiol; 1996 Nov; 169(2):248-55. PubMed ID: 8908192
[TBL] [Abstract][Full Text] [Related]
10. Human retinoblastoma gene product prevents c-Ha-ras oncogene mediated cellular transformation of mouse fibroblasts.
Kivinen L; Pitkänen K; Laiho M
Oncogene; 1993 Oct; 8(10):2703-11. PubMed ID: 8378082
[TBL] [Abstract][Full Text] [Related]
11. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1.
Okimoto T; Kohno K; Kuwano M; Gopas J; Kung HF; Ono M
Oncogene; 1996 Apr; 12(8):1625-33. PubMed ID: 8622882
[TBL] [Abstract][Full Text] [Related]
12. Loss of glucocorticoid-dependent growth inhibition in transformed mouse lung cells.
Li J; Johnson TA; Hanson LA; Beer DG
Mol Carcinog; 1996 Aug; 16(4):213-20. PubMed ID: 8784464
[TBL] [Abstract][Full Text] [Related]
13. CD44 protein levels and its biological activity are regulated in Balb/c 3T3 fibroblasts by serum factors and by transformation with the ras but not with the sis oncogene.
Kogerman P; Sy MS; Culp LA
J Cell Physiol; 1996 Nov; 169(2):341-9. PubMed ID: 8908201
[TBL] [Abstract][Full Text] [Related]
14. Altered extracellular matrices influence cellular processes and nuclear matrix organizations of overlying human bladder urothelial cells.
Gordon JN; Shu WP; Schlussel RN; Droller MJ; Liu BC
Cancer Res; 1993 Oct; 53(20):4971-7. PubMed ID: 8402687
[TBL] [Abstract][Full Text] [Related]
15. EJ-ras oncogene transfection of endothelial cells upregulates the expression of syndecan-4 and downregulates heparan sulfate sulfotransferases and epimerase.
Lopes CC; Toma L; Pinhal MA; Porcionatto MA; Sogayar MC; Dietrich CP; Nader HB
Biochimie; 2006 Oct; 88(10):1493-504. PubMed ID: 16793191
[TBL] [Abstract][Full Text] [Related]
16. Loss of growth factor dependence and conversion of transforming growth factor-beta 1 inhibition to stimulation in metastatic H-ras-transformed murine fibroblasts.
Schwarz LC; Gingras MC; Goldberg G; Greenberg AH; Wright JA
Cancer Res; 1988 Dec; 48(24 Pt 1):6999-7003. PubMed ID: 3056609
[TBL] [Abstract][Full Text] [Related]
17. Restored expression of transforming growth factor beta type II receptor in k-ras-transformed thyroid cells, TGF beta-resistant, reverts their malignant phenotype.
Coppa A; Mincione G; Lazzereschi D; Ranieri A; Turco A; Lucignano B; Scarpa S; Ragano-Caracciolo M; Colletta G
J Cell Physiol; 1997 Aug; 172(2):200-8. PubMed ID: 9258341
[TBL] [Abstract][Full Text] [Related]
18. [Involvement of cAMP dependent protein kinase in the reversion of a NIH/3T3 cell line transformed by a ras oncogene (EJ-NIH/3T3)].
Oda A
Hokkaido Igaku Zasshi; 1988 Sep; 63(5):747-53. PubMed ID: 3071519
[TBL] [Abstract][Full Text] [Related]
19. p21ras-mediated decrease of the retinoblastoma protein in fibroblasts occurs through growth factor-dependent mechanisms.
Kivinen L; Tiihonen E; Haapajärvi T; Laiho M
Cell Growth Differ; 1996 Dec; 7(12):1705-12. PubMed ID: 8959339
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor and the control of proliferation of Balb 3T3 and benzo[a]pyrene-transformed Balb 3T3 cells.
Brown KD; Holley RW
J Cell Physiol; 1979 Jul; 100(1):139-46. PubMed ID: 313933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
